NorthWest Biotherapeutics Inc (NWBO)

[HyGro]

NWBO was desperate as they certainly don't have the time or money to do another decade of P3 trial again. Whe FDA said don't bother filing with them, they looked for the best option and with Advent in UK and EU a tougher reviewer, they went UK. But even that required years of review likely with several RFI's to answer questions about trial design. It's make or break for NWBO -- it they fail they'll become a contract manufacturing company.